Targeted Metabolomic Biomarkers for Stroke Subtyping
Translational Stroke Research · 2024-04 · 15 (2) · 422-432
DOI: 10.1007/s12975-023-01137-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 11.02.2023. Verfasst von Eung-Joon Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Stroke, Atherosclerosis, Ischemic Stroke, Embolic Stroke. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: Ischemic stroke is a heterogeneous disease with various etiologies. The current subtyping process is complicated, time-consuming, and costly. Metabolite-based biomarkers have the potential to improve classification and deliver optimal treatments. We here aimed to identify novel, targeted metabolomics-based biomarkers to discriminate between large-artery atherosclerosis (LAA) and cardioembolic (CE) stroke. METHODS: We acquired serum samples and clinical data from a hospital-based acute stroke registry (ischemic stroke within 3 days from symptom onset). We included 346 participants (169 LAA, 147 CE, and 30 healthy older adults) and divided them into training and test sets. Targeted metabolomic analysis was performed using quantitative and quality-controlled liquid chromatography with tandem mass spectrometry. A multivariate regression model using metabolomic signatures was created that could independently distinguish between LAA and CE strokes. RESULTS: The training set (n = 193) identified metabolomic signatures that were different in patients with LAA and CE strokes. Six metabolomic biomarkers, i.e., lysine, serine, threonine, kynurenine, putrescine, and lysophosphatidylcholine acyl C16:0, could discriminate between LAA and CE stroke after adjusting for sex, age, body mass index, stroke severity, and comorbidities. The enhanced diagnostic power of key metabolite combinations for discriminating between LAA and CE stroke was validated using the test set (n = 123). CONCLUSIONS: We observed significant differences in metabolite profiles in LAA and CE strokes. Targeted metabolomics may provide enhanced diagnostic yield for stroke subtypes. The pathophysiological pathways of the identified metabolites should be explored in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
- Metabolomics Core Facility, Department of Transdisciplinary Research and Collaboration, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Neurology, Uijeongbu Eulji Medical Center, Uijeongbu-si, Republic of Korea.
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. joocho@snu.ac.kr.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. joocho@snu.ac.kr.
Zitieren
APA
Lee, E. J., Kim, D. J., Kang, D. W., Yang, W., Jeong, H. Y., Kim, J. M., Ko, S. B., Lee, S. H., Yoon, B. W., Cho, J. Y., & Jung, K. H. (2024). Targeted Metabolomic Biomarkers for Stroke Subtyping. Translational Stroke Research, 15(2), 422-432. https://doi.org/10.1007/s12975-023-01137-5
Vancouver
Lee EJ, Kim DJ, Kang DW, Yang W, Jeong HY, Kim JM, et al. Targeted Metabolomic Biomarkers for Stroke Subtyping. Translational Stroke Research. 2024;15(2):422-432. doi:10.1007/s12975-023-01137-5
BibTeX
@article{Lee2024,
author = {Lee, Eung-Joon and Kim, Da Jung and Kang, Dong-Wan and Yang, Wookjin and Jeong, Han-Yeong and Kim, Jeong-Min and Ko, Sang-Bae and Lee, Seung-Hoon and Yoon, Byung-Woo and Cho, Joo-Youn and Jung, Keun-Hwa},
title = {Targeted Metabolomic Biomarkers for Stroke Subtyping},
journal = {Translational Stroke Research},
year = {2024},
volume = {15},
number = {2},
pages = {422--432},
doi = {10.1007/s12975-023-01137-5}
}
EUVIMED